Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
29.89
-0.03 (-0.10%)
At close: Dec 16, 2025, 4:00 PM EST
29.80
-0.09 (-0.32%)
After-hours: Dec 16, 2025, 7:55 PM EST
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
$384,828
Profits / Employee
-$537,241
Market Cap
11.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MRNA News
- 1 day ago - EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) - Accesswire
- 14 days ago - Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 15 days ago - S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia Partnership - Investopedia
- 15 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 15 days ago - Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More - Investopedia
- 15 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 15 days ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 22 days ago - Moderna, Inc. (MRNA) Analyst/Investor Day Transcript - Seeking Alpha